AI-based glaucoma screening program in Barcelona
Barcelona Esquerra Glaucoma Artificial Intelligence-based Screening Program (BEGAS): Artificial Intelligence Applied to Optic Nerve Retinographies for a Glaucoma Screening Program in a Primary-care Setting
NA · Hospital Clinic of Barcelona · NCT06353542
This study is testing whether an AI program or an eye doctor is better at spotting glaucoma in people aged 45 to 64 during a single eye exam in Barcelona.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 500 (estimated) |
| Ages | 40 Years to 80 Years |
| Sex | All |
| Sponsor | Hospital Clinic of Barcelona (other) |
| Locations | 1 site (Barcelona, Barcelona) |
| Trial ID | NCT06353542 on ClinicalTrials.gov |
What this trial studies
This program aims to evaluate two different screening methods for identifying patients with referable glaucoma in Barcelona. Participants aged 45 to 64 will undergo a one-time visit for an optic disc examination and intraocular pressure measurement. One group will have their optic disc images analyzed by an Artificial Intelligence (AI) software, while the other will be assessed by an ophthalmologist. The study will compare the diagnostic accuracy and cost-effectiveness of both approaches.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 45 to 64 living in the metropolitan area of Barcelona with a family history of glaucoma.
Not a fit: Patients with a prior diagnosis of glaucoma or significant ophthalmic diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could enhance early detection of glaucoma, leading to better patient outcomes.
How similar studies have performed: Other studies have shown promise in using AI for glaucoma screening, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 40 to 80 years old from our reference population * Family history of glaucoma * Willingness to participate * Signed written informed consent Exclusion Criteria: * Not signing the informed consent * Patients that had a previous diagnosis of glaucoma or any ophthalmic disease that required a regular ophthalmic examination and/or treatment * Congenital or childhood glaucoma * History of strabismus or amblyopia * Known ophthalmic diseases which imply media opacity (cataract, cornea opacities) that might preclude from taking fundus retinographies
Where this trial is running
Barcelona, Barcelona
- Hospital Clínic - ICOF — Barcelona, Barcelona, Spain (RECRUITING)
Study contacts
- Study coordinator: Nestor Ventura Abreu, MD, PhD
- Email: neventura@clinic.cat
- Phone: +34932275400
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Glaucoma, Artificial Intelligence, Diagnostic Test: Glaucoma Screening